FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies
Clinical trial NCT04245722 · TERMINATED
Trial details
- NCT number
- NCT04245722
- Sponsor
- Fate Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-19
- Primary completion
- 2023-09-27
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.